Status:
COMPLETED
Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism (VTE), which clinically manifests as deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common but elusive illness that can cause significant disability and death if n...
Eligibility Criteria
Inclusion
- Adult \> 18 years of age who either present to either hospital with acute PE or develop acute PE while admitted to the hospital diagnosed by CT
- Capable of informed consent
Exclusion
- Contraindication to CT scanning
- Cannot provide written informed consent.
- Patients do not speak English, or have dementia and do not have a proxy who could participate in follow-up interviews.
- Pregnant or lactating females.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
910 Patients enrolled
Trial Details
Trial ID
NCT00805246
Start Date
December 1 2008
End Date
May 1 2017
Last Update
September 11 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis
St Louis, Missouri, United States, 63130
2
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213